NeuroRegulation

NeuroRegulation is a peer-reviewed journal providing an integrated, multidisciplinary perspective on clinically relevant research, treatment, and public policy for neuroregulation and neurotherapy.  NeuroRegulation reviews important findings in these fields with a focus on electroencephalography (EEG), neurofeedback, quantitative electroencephalography (qEEG), psychophysiology, biofeedback, heart rate variability, repetitive Transcranial Magnetic Simulation (rTMS) and transcranial direct current stimulation (tDCS); with a focus on treatment of psychiatric, mind-body, and neurological disorders.  The journal is open access with no submission fees or APC (Author Processing Charges).   NeuroRegulation is the official publication of the International Society for Neurofeedback and Research (ISNR) and is indexed in the Abstracting & Indexing databases of SCOPUS, Elsevier's Embase, Google Scholar and DOAJ.  [ISSN: 2373-0587]

  • CiteScore™ Tracker 2018 = 0.54
Calculated by Scopus on November 12, 2018. Available from: https://www.scopus.com/sourceid/21100854898#tabs=0

To view and download the most CURRENT issue CLICK HERE, click on the Journal cover image below, or scroll down below the announcements.

To access BACK issues CLICK HERE, or click on the word "ARCHIVES" on the menu at the top of this page.

 

 

 


Announcements

 

CALL for PAPERS - Submission Deadline

 

NeuroRegulation welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence, and will publish:

    Original articles in basic and applied research
    Case studies
    Critical reviews, surveys, opinions, perspectives, commentaries and essays

Submissions are being accepted for consideration in the first issue of Volume 6, scheduled for publication in March 2019.

Deadline:  February 3, 2019

Note:  Early submissions are strongly encouraged to allow adequate time for the manuscript review process. Also, all submissions must be made only through this journal website.

NeuroRegulation provides the following benefits to authors:

  • Open-Access - means free and open global visibility
  • No author fees - no need to pay for publication
  • CiteScore - impact factor via monthly Scopus CiteScore Tracker (Available from: https://www.scopus.com/sourceid/21100854898#tabs=0 )
  • Expedited publishing - current average 6 days submission to review & 50 days submission to publication
  • Indexed in Scopus - the largest abstract and citation database of peer-reviewed literature
  • Indexed in ELSEVIER Embase - the most important international biomedical literature from 1947 to the present day
 
Posted: 2018-12-04
 

Register for Notifications/Announcements

 
If you wish to recieve notifications of Announcements (i.e. submission deadlines), and when new issues are published, register as a user and set your notification alerts accordingly.  
Posted: 2015-07-10
 
More Announcements...

Vol 5, No 4 (2018)

Full Issue

View or download the full issue PDF

Table of Contents

Contents
 
PDF
106

Editorials

Rex L Cannon
PDF
107

Research Papers

Connie J McReynolds, Lelah S. Villalpando, Cynthia E. Britt
PDF
109
Laura Barry, Gregory L. Nooney
PDF
129

Perspectives

Kirtley E. Thornton
PDF
137

Proceedings

 
PDF
150